On July 7, 2026, OTR Therapeutics, a clinical-stage biotechnology firm, revealed a new strategic partnership with LG Chem. The aim is to collaborate and develop global therapies from early-stage innovations. LG Chem, a prominent global company, will be working closely with OTR Therapeutics on this initiative.
